SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Clarification from Wintac

24 Jul 2015 Evaluate

Wintac has informed that Further to the news item from Lupin about their acquisition of Gavis Pharmaceuticals LLC, USA and Novel Laboratories Inc., USA, there is an abnormal increase in the volume and share price of Wintac, Bangalore as GAVIS Pharma LLC is the promoter and holding company of Wintac. They would like to inform that GAVIS Pharma LLC, USA has clarified that Lupin has not acquired Wintac and/or its holding company GAVIS Pharma LLC, USA. Gavis Pharma and Gavis Pharmaceuticals are two different companies and that Lupin has acquired only Gavis Pharmaceuticals.

The above information is a part of company’s filings submitted to BSE.

Wintac Share Price

341.60 0.00 (0.00%)
17-Dec-2020 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1234.20
Cipla 1233.35
Zydus Lifesciences 938.70
Lupin 2326.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×